Assessment of utility of Homoeopathic medicines in Psoriasis

Utility of Homoeopathy in Psoriasis using Dermatology Life Quality Index Scale - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090789

Enrollment

Registered

2025-07-11

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

Intervention1: homoeopathic medicine: homoeopathic medicine as per requirement of case in duration of 9 months Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Patient of all genders and aged 16 years and above, diagnosed with psoriasis clinically or by a Dermatologist Patients irrespective of socioeconomic condition and religion are included Patient with no prior systemic treatment for Psoriasis with the last 6 months Participants who can attend regular follow-up visits every 4 weeks for 9 months

Exclusion criteria

Exclusion criteria: Patients with critical conditions such as erythrodermic psoriasis or generalised pustular psoriasis(GPP) Individual with severe uncontrolled systemic illnesses like diabetes or hypertention Patients on immunosuppressive therapy or those with a history of malignancies

Design outcomes

Primary

Measure	Time frame
subjective improvement in symptoms of Psoriasis affecting day to day life using DLQI scaleTimepoint: subjective improvement in symptoms of Psoriasis affecting day to day life	—

Secondary

Measure	Time frame
disappearance or diminish of lesions of PsoriasisTimepoint: 9 months	—

Countries

India

Contacts

Public ContactDr Meera Barvaliya

C D Pachchigar College of Homoeopathic Medicine and Hospital

meeradesai4141@gmail.com7874401997

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026